Drug Approval | March 25, 2023
Zydus receives final approval from USFDA for Doxepin Hydrochloride Capsules USP, 150 mg
Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety
Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety
Lubiprostone capsule is indicated to treat certain types of constipation (chronic idiopathic constipation and irritable bowel syndrome with constipation)
Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).
hubergroup’s two newly added medical vans are dedicated to dental and eye care
PM emphasises the need to enhance lab surveillance & testing of all Severe Acute Respiratory Illness (SARI) cases & ramp up genome sequencing
Integration of modern and traditional medicine to facilitate the illness to wellness journey
PM to launch TB-Mukt Panchayat initiative; official pan-India rollout of a shorter TB Preventive Treatment and Family-centric care model for TB
Essex enriches and complements Emmes’ services
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
Subscribe To Our Newsletter & Stay Updated
